Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H24N2OS |
| Molecular Weight | 328.472 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCSC(=O)N(C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=BZGIPVGCJGXQTA-UHFFFAOYSA-N
InChI=1S/C19H24N2OS/c1-3-20(4-2)15-16-23-19(22)21(17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14H,3-4,15-16H2,1-2H3
Phencarbamide is an anti-spasmodic and anticholinergic drug used during parturition. It has a specific antispasmodic action on the smooth muscle, both directly like papaverine and through the autonomic nervous system (atropine effect). It has also an analgesic effect of its own. Side-effects generally associated with the atropine group of drugs.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Propranolol-bunolol and phencarbamide in chloroform-induced ventricular fibrillation in mice. | 1973-06 |
|
| [Colorimetric determination of phencarbamide and its hydrochloride and naphthalene disulfonate salts]. | 1971-11 |
|
| Anticonvulsant effect of phencarbamide and its modification by reserpine and tranylcypromine. | 1971-03 |
|
| A study of the antiarrhythmic and local anaesthetic actions of phencarbamide. | 1970-05 |
|
| [Spasmolytic effect of phencarbamide on the uterine cervix during early puerperium]. | 1966-08-26 |
|
| [PRACTICAL EXPERIENCES WITH THE SPASMOLYTIC AGENT ESCORPAL IN OBSTETRICS]. | 1965-01-30 |
|
| [SPASMOLYSIS IN OBSTETRICS: CLINICAL EXPERIENCE WITH PHENCARBAMIDE]. | 1964-09-26 |
|
| [EXPERIENCES WITH A NEW SPASMOLYTIC AGENT (ESCORPAL) IN OBSTETRICS]. | 1964-06-20 |
|
| [PHENCARBAMIDE, A NEW SPASMOLYTIC COMBINED WITH DOLVIRAN]. | 1964-06 |
|
| [On the pharmacology of the uterine action of phencarbamide]. | 1963 |
|
| [On the clinical experiences with the spasmolytic Bayer 1355 (phencarbamide) in obstetrics]. | 1963 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29704
Created by
admin on Mon Mar 31 18:30:27 GMT 2025 , Edited by admin on Mon Mar 31 18:30:27 GMT 2025
|
||
|
NCI_THESAURUS |
C29696
Created by
admin on Mon Mar 31 18:30:27 GMT 2025 , Edited by admin on Mon Mar 31 18:30:27 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C66369
Created by
admin on Mon Mar 31 18:30:27 GMT 2025 , Edited by admin on Mon Mar 31 18:30:27 GMT 2025
|
PRIMARY | |||
|
SUB07546MIG
Created by
admin on Mon Mar 31 18:30:27 GMT 2025 , Edited by admin on Mon Mar 31 18:30:27 GMT 2025
|
PRIMARY | |||
|
100000081246
Created by
admin on Mon Mar 31 18:30:27 GMT 2025 , Edited by admin on Mon Mar 31 18:30:27 GMT 2025
|
PRIMARY | |||
|
6008
Created by
admin on Mon Mar 31 18:30:27 GMT 2025 , Edited by admin on Mon Mar 31 18:30:27 GMT 2025
|
PRIMARY | |||
|
223-103-4
Created by
admin on Mon Mar 31 18:30:27 GMT 2025 , Edited by admin on Mon Mar 31 18:30:27 GMT 2025
|
PRIMARY | |||
|
m395
Created by
admin on Mon Mar 31 18:30:27 GMT 2025 , Edited by admin on Mon Mar 31 18:30:27 GMT 2025
|
PRIMARY | Merck Index | ||
|
59H17J9F1B
Created by
admin on Mon Mar 31 18:30:27 GMT 2025 , Edited by admin on Mon Mar 31 18:30:27 GMT 2025
|
PRIMARY | |||
|
3735-90-8
Created by
admin on Mon Mar 31 18:30:27 GMT 2025 , Edited by admin on Mon Mar 31 18:30:27 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107472
Created by
admin on Mon Mar 31 18:30:27 GMT 2025 , Edited by admin on Mon Mar 31 18:30:27 GMT 2025
|
PRIMARY | |||
|
1324
Created by
admin on Mon Mar 31 18:30:27 GMT 2025 , Edited by admin on Mon Mar 31 18:30:27 GMT 2025
|
PRIMARY | |||
|
DTXSID80190796
Created by
admin on Mon Mar 31 18:30:27 GMT 2025 , Edited by admin on Mon Mar 31 18:30:27 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
